Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-226942
Filing Date
2019-08-22
Accepted
2019-08-22 17:01:01
Documents
7
Effectiveness Date
2019-08-22

Document Format Files

Seq Description Document Type Size
1 S-8 d797111ds8.htm S-8 68585
2 EX-5.1 d797111dex51.htm EX-5.1 8118
3 EX-23.1 d797111dex231.htm EX-23.1 1628
4 EX-99.2 d797111dex992.htm EX-99.2 75567
5 EX-99.3 d797111dex993.htm EX-99.3 56252
6 GRAPHIC g797111g0822130911437.jpg GRAPHIC 2532
7 GRAPHIC g797111g0822131544657.jpg GRAPHIC 647
  Complete submission text file 0001193125-19-226942.txt   215884
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233414 | Film No.: 191046575
SIC: 2834 Pharmaceutical Preparations